| PHYSICIANS’ CONFERENCE PROGRAM | |||||||
| Day 01 | May 04, 2024 (Saturday) | |||||||
| (The timings mentioned are as per the Indian Standard Time – IST) | |||||||
| Hall A | Hall B | ||||||
| Timings | Topic | Speakers | Timings | Topic | Speakers | ||
| 9:00 AM – 10:00 AM | Oral Session 1 (7 mins talk + 3 mins Q&A) Judges: Dr Mallikarjuna, Dr Shweta Bansal, Dr Harshit Khurana |
9:00 AM – 10:00 AM | Oral Session 2 (7 mins talk + 3 mins Q&A) Judges: Dr Santhosh Kumar, Dr Dinesh Bhurani, Dr Aruna Rajendran |
||||
| 09:00 AM – 09:10 AM | Pediatric Intensive Care Post Hematopoietic Stem Cell Transplantation – There Is Light at The End Of The Tunnel (Abstract ID: 94) |
Dr Nalla Anuraag Reddy | 09:00 AM – 09:10 AM | Transplant Outcomes In Patients With AML in CR1 (Abstract ID: 136) |
Dr Ayushi Gupta | ||
| 09:10 AM – 09:20 AM | Hematopoietic Stem Cell Transplantation (HSCT) in children with Thalassemia major- A single center experience from southern part of India (Abstract ID: 109) |
Dr Tanusree Paul | 09:10 AM – 09:20 AM | Chimerism analysis in pediatric Transfusion Dependent Thalassemia patients with Treosulphan based conditioning (Abstract ID: 107) |
Dr Krisha Shah | ||
| 09:20 AM – 09:30 AM | The spectrum of atypical Graft-Versus-Host-Disease in children undergoing Hematopoietic Stem Cell Transplantation (Abstract ID: 101) |
Dr Anupama Nair | 09:20 AM – 09:30 AM | Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia in Era of Tyrosine Kinase Inhibitors -A 13-year single Centre experience from India (Abstract ID: 77) |
Dr Mehak Trikha | ||
| 09:30 AM – 09:40 AM | Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia- A Comparison between haplo-identical and full-matched related donor transplants. (Abstract ID: 60) |
Dr Samyukta Shyam | 09:30 AM – 09:40 AM | A Comparative Analysis of Two Forms of Rabbit Anti Thymocyte Globulin As Serotherapy In Paediatric and Young Adult’s Undergoing Hematopoietic Stem Cell Transplant (Abstract ID: 22) |
Dr Garima Nirmal | ||
| 09:40 AM – 09:50 AM | Stringent therapeutic drug monitoring of Cyclosporine decreases the incidence of acute GVHD: An effective audit trail (Abstract ID: 146) |
Dr Sagar Kanta | 09:40 AM – 09:50 AM | T-Cell Reconstitution Can be a Predictive Biomarker for Severe Acute GvHD in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with a Treosulfan/Fludarabine Conditioning Regimen (Abstract ID: 97) |
Dr Rachel Mariam Renji | ||
| 09:50 AM – 10:00 AM | Use of Faecal Microbiota Transplant (FMT) in steroid refractory acute Graft Versus Host disease (aGVHD) patients: a single centre experience. (Abstract ID: 7) |
Dr Devika Manikonda | 09:50 AM – 10:00 AM | The Safety and Efficacy of Romiplostim in Haematopoietic Stem Cell Transplant in Platelet Recovery (Abstract ID: 35) |
Dr Madhupriya B | ||
| 10:00 AM – 11:00 AM | Session 1: Leukaemia Chairpersons: Dr Hari Menon, Dr Jose Easow |
10:00 AM – 11:00 AM | Session 5: Paediatric Session 1 Chairpersons: Dr Veerendra Patil, Dr Ponni Sivaprakasam |
||||
| 10:00 AM – 10:15 AM | Refractory AML – Role of HSCT Conditioning | Dr Rishi Dhawan | 10:00 AM – 10:15 AM | Graft Manipulation for haploidentical HSCT | Dr Gaurav Kharya | ||
| 10:15 AM – 10:20 AM | Q&A / Discussion | 10:15 AM – 10:20 AM | Q&A / Discussion | ||||
| 10:20 AM – 10:35 AM | Unique complications in HSCT for R/R ALL | Dr Jeevan Kumar | 10:20 AM – 10:35 AM | HSCT for fanconi anaemia in India | Dr Sushil Selvarajan | ||
| 10:35 AM – 10:40 AM | Q&A / Discussion | 10:35 AM – 10:40 AM | Q&A / Discussion | ||||
| 10:40 AM – 10:55 AM | The perfect match “walking the maze to prevent the relapse in patients with leukaemia” |
Dr Sarita Jaiswal | 10:40 AM – 10:55 AM | Trageted Busulfan- Bench to bedside in CMC | Dr Poonkuzhali | ||
| 10:55 AM – 11:00 AM | Q&A / Discussion | 10:55 AM – 11:00 AM | Q&A / Discussion | ||||
| 11:00 AM- 11:30 AM | Coffee Break | 11:00 AM- 11:30 AM | Coffee Break | ||||
| 11:30 AM- 11:45 AM | Inaugural Ceremony | 11:30 AM- 11:45 AM | Inaugural Ceremony | ||||
| 11:50 AM – 01:00 PM | Session 2: Myeloma/Lymphoma Chairpersons: Dr Sameer Mellinkeri, Dr Steve Thomas |
11:50 AM – 01:00 PM | Session 6: Paediatric Session 2 Chairpersons: Dr Alka Khadwal, Dr Shivani Patel |
||||
| 11:50 AM – 12:05 PM | CAR T upfront for Myeloma | Dr Ranjit Sahoo | 11:50 AM – 12:05 PM | Haploidentical HSCT for Thalassemia Major In India | Dr Satya Prakash Yadav | ||
| 12:05 PM – 12:20 PM | ALLOGRAFT for Hodgins Lymphoma | Dr Nishant Jindal | 12:05 PM – 12:20 PM | Alternate donor HSCT for IEI | Dr Ramya Uppuluri | ||
| 12:20 PM – 12:35 PM | CAR T in NHL | Dr Sachin Punatar | 12:20 PM – 12:45 PM | Panel Discussion – Difficult and rare scenarios |
Moderator: Dr Neha Rastogi Panelists: Dr Anand Prakash, Dr Sirisha Rani, Dr Manas Kalra, Dr Deepa Trivedi |
||
| 12:35 PM – 12:50 PM | PTLD | Dr Pravas Mishra | 12:45 PM – 01:00 PM | SOS | Dr Stalin Ramprakash | ||
| 12:50 PM – 01:00 PM | Discussion | ||||||
| 01:15 PM – 02:00 PM | Industry Lunch Symposium by Sanofi | 01:15 PM – 02:00 PM | Industry Lunch Symposium by Emcure | ||||
| 01:15 PM – 01:30 PM | What’s new in cGVHD | Dr. Rahul Bhargava | “Pediatric HSCT” | ||||
| 01:30 PM – 01:55 PM | Panel Discussion – Preventing cGVHD | Moderator : Dr. Sameer Melinkeri Panelists : Dr. Dharma Chaudhary, Dr. Sunil Bhat |
01:15 PM – 01:25 PM | Inborn errors of immunity in pediatric HSCT Focus: TFT |
Dr Gaurav Kharya | ||
| 01:25 PM – 01:35 PM | Pediatric AML Focus: Thio vs Bu-Flu |
Dr Vikas Dua | |||||
| 01:35 PM – 01:55 PM | Panel Discussion – Pediatric HSCT | Moderator: Dr Satya Prakash Yadav Panelists: Dr Santanu Sen Dr Chintan Vyas Dr Sushil S Dr Anand Prakash Dr Sirisha Rani |
|||||
| 02:15 PM – 03:30 PM | Session 3: Supportive Care / Infections Chairperson: Dr Ruchira Misra |
||||||
| 02:15 PM – 02:30 PM | TATMA – What is new? | Dr Gaurav Prakash | |||||
| 02:30 PM – 02:45 PM | MDR Infections- Innovative solutions | Dr Ganesh Jaishetswar | |||||
| 02:45 PM – 03:00 PM | Vaccinations Post HSCT | Dr Joseph John | |||||
| 03:00 PM – 03:15 PM | Update on CMV in HSCT | Dr Vikas Dua | |||||
| 03:15 PM – 03:30 PM | Discussion | ||||||
| 03:30 PM – 05:00 PM | Session 4: Transplant Immunology/GVHD Chairperson: Dr Krishnarathnam Kannan, Dr. Ramaswamy N.V |
||||||
| 03:30 PM – 03:45 PM | Role of TPO in poor graft function | Dr Pankaj Malhotra | |||||
| 03:45 PM – 03:50 PM | Q&A / Discussion | ||||||
| 03:50 PM – 04:05 PM | Pulmonary Complications in HSCT | Dr Anupam Chakrapani | |||||
| 04:05 PM – 04:10 PM | Q&A / Discussion | ||||||
| 04:10 PM – 04:25 PM | Donor Specific Antibodies – Strategies to overcome Graft Rejection | Dr Uday Kulkarni | |||||
| 04:25 PM – 04:30 PM | Q&A / Discussion | ||||||
| 04:30 PM – 05:00 PM | Panel Discussion: Follow up with precision |
Moderator: Dr Kannan Subramanian Panelists: Dr Jasmeet Kaur, Dr Thulasiraman, Dr Rizwan Javed |
|||||
| 05:00 PM – 06:00 PM | Coffee Break & Poster Session | Poster Judges: Dr Vasundhara kailasnath, Dr Kishore Kumar, Dr Chandran K Nair, Dr Vimal Kumar |
05:00 PM – 06:00 PM | Coffee Break & Meeting With MUD Registries | Panel Discussion: On unrelated Registries Moderator: Dr Rasmi Palassery Panelist: Ms Sumati Misra, Mr Mathew Cyriac, Dr Laxmanan, Dr Vipin Khandelwal, Dr.Praveen Clement |
||
| 06:00 PM – 06:45 PM | Industry Symposium by Emcure | 06:00 PM – 06:45 PM | Industry Symposium | ||||
| Adult HSCT | |||||||
| 06:00 PM – 06:10 PM | Adult AML Focus: Treo-Flu |
Dr Ganesh Jaishetwar | |||||
| 06:10 PM – 06:20 PM | CNS Lymphoma Focus: Thiotepa |
Dr Sachin Jadhav | |||||
| 06:20 PM – 06:40 PM | Panel Discussion – Adult HSCT | Moderator: Dr Sameer Melinkeri Panelists: Dr Esha Kaul Dr Neeraj Siddharthan Dr Sanjeev Yadav Dr Rajib De Dr Joseph John |
|||||
| 07:00 PM – 08:15 PM | ISBMT Registry Meeting and AGM | ||||||
| 08:15 PM Onwards | Dinner | ||||||
| Physicians’ Conference Program | ||
| Day 02 | May 05, 2024 (Sunday) | ||
| (The timings mentioned are as per the Indian Standard Time – IST) | ||
| Hall A | ||
| Timings | Topic | Speaker |
| 08:00 AM – 09:00 AM | Meet the Experts Table 1: How to establish a CAR T program – Dr Padmaja lokireaddy, Dr Prashant Mehta Table 2: Treosulfan in HSCT – Dr Punit Jain, Dr Deenadayalan Table 3: Therapy options for R/R NHL – Dr Dinesh Bhurani, Dr Sandip Shah Table 4: Steroid refractory acute GvHD – Dr Arijit Nag, Dr Rahul Naithani Table 5: Gene therapy in India – Dr Alok Srivastava, Dr Satyendra Katewa Table 6: Creating a network of HSCT centers – Dr Rahul Bhargava, Dr Sachin Jhadav |
|
| 09:00 AM – 10:40 AM | Session 6: Presidential Symposium “Changing trends in donor choice for HSCT” Moderator: Dr Shashikan Apte, Dr Navin Khattry |
|
| 09:00 AM – 09:25 AM | ASTCT | Dr Uday Poppat |
| 09:25 AM – 09:50 AM | EBMT | Dr Anna Sureda |
| 09:50 AM – 10:15 AM | APBMT | Dr Alok Srivastava |
| 10:15 AM – 10:40 AM | ISBMT | Dr Mammen Chandy |
| 10:40 AM – 11:00 AM | Coffee Break | |
| 11:00 AM – 11:45 AM | Industry Symposium (Pfizer) | |
| Panel Discussion: Transforming the treatment Paradigm of R/R adult B Cell ALL with Inotuzumab |
Moderator: Dr Sharat Damodar Speaker: Dr Rahul Nathani Panelists: Dr Padmaja Lokireddy Dr Uday Kulkarni Dr Arijit Nag |
|
| 11:45 AM – 01:15 PM | Session 7: Cellular Therapy Chairperson: Dr Shashikant Apte, Dr Chirag Shah |
|
| 11:45 AM – 12:00 PM | CAR T beyond CD19 | Dr Sunil Bhat |
| 12:00 PM – 12:05 PM | Q&A / Discussion | |
| 12:05 PM – 12:20 PM | Point of care CAR T Cells – Singapore Experience | Dr Michaela Seng |
| 12:20 PM – 12:25 PM | Q&A / Discussion | |
| 12:25 PM – 12:40 PM | The TMH Experience – CAR-T Cells | Dr Gaurav Narula |
| 12:40 PM – 12:45 PM | Q&A / Discussion | |
| 12:45 PM – 01:15 PM | Panel Discussion: Road Map for CAR T program in India |
Moderator: Dr Navin Khattry Panelists: Dr Prashant Tembhare, Dr Shashikant Apte, Dr Sharad Damodar |
| 01:30 PM – 01:45 PM | Valedictory Ceremony | |
| 01:45 PM – 02.45 PM | Lunch and Working Group Meeting | |
